Combining polygenic risk scores to understand genetic liability to physical-mental health multimorbidity in UK Biobank
Authors:
- Daniel StowDSDaniel Stow
- Ruby S M TsangRTRuby S M Tsang
- Ioanna K KatzourouIKIoanna K Katzourou
- Jack F G UnderwoodJUJack F G Underwood
- LIfespaN multimorbidity research Collaborative (LINC)L(LIfespaN multimorbidity research Collaborative (LINC)
- Inês BarrosoIBInês Barroso
- Marianne B M van Den BreeMarianne B M van Den Bree
- Sarah FinerSFSarah Finer
- Nicholas J TimpsonNTNicholas J Timpson
Open Access
- 15 April 2026
- journal article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 35 (7)
Abstract
Background: Multimorbidity, also known as multiple long-term conditions, is a major public health concern. Internalising and CardioMetabolic MultiMorbidity (ICM-MM) is a common form of mental-physical health multimorbidity, yet its genetic predisposition is largely unknown. We examined the polygenic nature of ICM-MM by assessing single trait-specific polygenic risk scores (PRSTRAIT) and whether combining them could increase the proportion of variance in liability to ICM-MM explained by genetic variation. Methods: We developed PRSTRAIT using PRS-CS and summary statistics from the largest trait-specific GWAS excluding UK Biobank (UKB). We evaluated PRSTRAIT on ICM-MM risk in 206 452 UKB participants (n = 39 311 (19.0%) with ICM-MM) using logistic regression adjusted for gender and 10 genetic principal components, defining ICM-MM as lifetime occurrence of: ≥1 internalising (depression, anxiety, somatoform disorder) traits AND ≥ 1 cardiometabolic traits (type 2 diabetes, obesity, hypertension, dyslipidemia, chronic kidney disease). We used elastic net regression in a 50% training sample to generate ICM-MM-PRSTRAIT: a weighted combination of PRSTRAIT targeting ICM-MM. Results: The strongest associations were between ICM-MM and PRSTRAIT for depression and type 2 diabetes—both odds ratios (OR) 1.18, [95% confidence interval (CI) 1.17–1.20] per standard deviation increase in PRSTRAIT. ICM-MM-PRSTRAIT retained five PRSTRAIT, with stronger associations (OR = 1.31, [95%CI 1.29–1.34]) than any PRSTRAIT in the testing sample. Discussion: Combining several PRS explains more variance in ICM-MM liability than single-trait PRSs alone. ICM-MM-PRSTRAIT is a measure of genetic risk that could be used to examine premorbid stages of ICM-MM in external and youth cohorts, supporting awareness of earlier presentation and potentially avoidance or intervention.Keywords
Funding Information
- Tackling Multimorbidity at Scale Strategic Priorities Fund programme (MR/W014416/1)
- Medical Research Council
- National Institute for Health and Care Research
- Engineering and Physical Sciences Research Council
- Wellcome Trust GW4-CAT Clinical Doctoral Fellowship (222849/Z/21/Z)
This publication has 77 references indexed in Scilit:
- A systematic analysis of the contribution of genetics to multimorbidity and comparisons with primary care dataEBioMedicine, 2025
- Assessing the importance of primary care diagnoses in the UK BiobankEuropean Journal of Epidemiology, 2024
- Interventions and management on multimorbidity: An overview of systematic reviewsAgeing Research Reviews, 2023
- Global and regional prevalence of multimorbidity in the adult population in community settings: a systematic review and meta-analysiseClinicalMedicine, 2023
- Interventions for improving outcomes in patients with multimorbidity in primary care and community settingsCochrane Database of Systematic Reviews, 2021
- Genetic comorbidity between major depression and cardio‐metabolic traits, stratified by age at onset of major depressionAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2020
- Major depressive disorder and cardiometabolic diseases: a bidirectional Mendelian randomisation studyDiabetologia, 2020
- Genetic Variants Associated With Anxiety and Stress-Related DisordersJAMA Psychiatry, 2019
- Polygenic Prediction of Weight and Obesity Trajectories from Birth to AdulthoodCell, 2019
- Promises and pitfalls of electronic health record analysisDiabetologia, 2017